NY A01057

Authorizes schools to possess and administer FDA approved opioid reversal agents in emergency situations to negate or neutralize, in whole or in part, the pharmacological effects of an opioid in the human body.

Introduced House Maritza Davila (D)
Plain English Summary

The bill allows schools in New York to keep and use FDA-approved medications that can reverse the effects of opioid overdoses during emergencies. This means that if a student or staff member is experiencing an opioid overdose, school personnel can administer these medications to help them recover. The goal is to save lives and provide immediate assistance in critical situations.

Supporters Say

Supporters of the bill argue that it is a crucial step in combating the opioid crisis and ensuring the safety of students. By equipping schools with opioid reversal agents, they believe that lives can be saved and that schools can play an active role in addressing drug-related emergencies. This proactive measure demonstrates a commitment to student health and safety.

Critics Say

Critics may argue that allowing schools to administer opioid reversal agents could lead to misuse or create a false sense of security regarding drug use among students. They might express concerns about the training and preparedness of school personnel to handle such medical situations effectively. Additionally, some may see this as a way to sidestep addressing the root causes of substance abuse among youth.

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us

About This Analysis

This summary was generated using AI from the bill's official text and metadata. Data sourced from LegiScan and the New York State Legislature. Conflict-of-interest analysis for this bill is coming soon.